EGFR, FLT1 and heparanase as markers identifying patients at risk of short survival in cholangiocarcinoma.

EGFR, FLT1 and heparanase as markers identifying patients at risk of short survival in cholangiocarcinoma.

BACKGROUND: Cholangiocarcinoma remains to be a tumor with very few treatment choices and limited prognosis. In this study, we sought to determine the prognostic role of fms-related tyrosine kinase 1/vascular endothelial growth factor receptor 1 (FLT1/VEGFR1), heparanase (HPSE) and epidermal growth f...

Full description

Bibliographic Details
Main Authors: Andreas-Claudius Hoffmann, Eray Goekkurt, Peter V Danenberg, Sylvia Lehmann, Gerhard Ehninger, Daniela E Aust, Jan Stoehlmacher-Williams
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3660514?pdf=render

Internet

http://europepmc.org/articles/PMC3660514?pdf=render

Similar Items